Added Value Specialty

Pharmaceutical Products

Hexaphoenix involves in developments and offers a wide range of value added medicines / specialty pharmaceutical products in different indication fields for contract manufacturing including a reliable product supply chain.

Different indication fields:

  • Cardiovascular system
  • Central Nervous system
  • Oncology
  • Antineoplastic and immunomodulation agents
  • Critical care system

Oxytocin Injection

Aspirin Tablet

Bisoprolol Fumarate

Celecoxib

Erythromycin Stearate

Ezetimibe

Fluoxetine

Gliclazide XR

Gliclazide

Metformin SR

Nortriptyline

Promethazine

Paroxetine

Prochlorperazine

Terbinafine

Zolpidem

Alimemazine

Alimemazine

Baclofen

Carbocisteine

Ethosuximide

Ibuprofen SR

Ivabradin

Metoclopramide

Nefopam

Nitrofurantoin

Spironolactone

Anagrelide

Loperamide and Simethicone

Loperamide and Simethicone

Loperamide

Betahistine dihydrochloride

Desloratadine

Aspirin

Hydrocortisone

Fludrocortisone acetate
en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianpt Portugueseru Russianes Spanish

Strength: 100mg /200mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 75mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 250mg /500mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 1.25mg /2.5mg/3.75mg/5mg/7.5mg/10mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg/20mg/30mg/40mg/60mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD / ACTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 30mg/60mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 40/160mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 500mg/750mg/1000mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg/25mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10/25mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: Prochlorperazine |  Tablet |  5mg
Prochlorperazine (OTC) | Buccal Tablet | 3mg
Prochlorperazine (Prescription Only) | Buccal Tablet | 3mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 250 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 7.5mg/5ml, 30mg/5ml

Dosage: Syrup

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 5/10/20/25mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 375mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD / ACTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 250mg/5ml

Dosage: Syrup

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 800mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 5mg / 7.5mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 5mg/5ml

Dosage: Syrup

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 30 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 50/100mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 12.5/25/50/100mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 0.5mg / 0.75mg / 1.0mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 2mg + 125mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 2mg + 125mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 2mg

Dosage: ODT (Lingual) Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 8mg /16mg / 24mg /48mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 0.5mg / ml

Dosage: Oral Solution

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 500 mg / 1000mg

Dosage: Granules in Sachet

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 1mg/5mg/10mg

Dosage: Film Coated Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 62.5 mcg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 5 IU and 10 IU

Dosage: Injection

Approved Authority: WHO Prequalified and From EUGMP Approved Plant

Dossiers Available: Ready CTD

Bioequivalence (BE/BA) study: Not Required for Injection

Market Availability: Not available for Ghana, Tanzania, Vietnam, Sri Lanka.